Sirius Genomics

Recent Finacing

Grant

Recent Raise

Undisclosed

Sirius Genomics is a Vancouver-based drug-enabling company developing pharmacogenomic diagnostics to assess genomic correlations and predict patient responsiveness to recombinant human activated Protein C in severe sepsis.